[ Price : $8.95]
FDA grants Destiny Pharma a Qualified Infectious Disease Product designation for the XF-73 (exeporfinium chloride) and its use in ...[ Price : $8.95]
FDAs Endocrinologic and Metabolic Drugs Advisory Committee plans to review Mercks IMPROVE-IT trial and its support of supplemental...[ Price : $8.95]
A California federal court says plaintiffs claims that four diabetes drug manufacturers should have included a label warning about...[ Price : $8.95]
FDA clears two Hitachi Medical Systems America Scenaria models of CT scanners.[ Price : $8.95]
Forest Laboratories asks the Supreme Court to hear and reverse a 2nd Circuit Appeals Court decision that requires it to continue m...[ Price : $8.95]
FDA's Endocrinologic and Metabolic Drugs Advisory Committee will meet 12/14 to discuss the results of the IMPROVE-IT trial, which ...[ Price : $8.95]
Washington Legal Foundation and the Allied Educational Foundation urge the Supreme Court to hear an OTC ibuprofen labeling case to...[ Price : $8.95]
Stakeholders meeting with FDA on MDUFA 4 reauthorization say there should be more population diversity in medical device clinical ...